MedPage Today on MSN
Regulatory T-Cell Drug Promising for Eczema, With Hint for Asthma as Well
For the primary endpoint, Eczema Area and Severity Index (EASI) improved by 53-61% in a dose-dependent manner across the ...
13hon MSN
Lifelong drugs for autoimmune diseases don’t work well. Now scientists are trying something new
There's a new frontier in treating autoimmune diseases. Today's treatments tamp down the friendly fire but don't fix what's ...
Metabolism guides the activation states of regulatory T cells, the immune cells that prevent inappropriate activation of the immune system. St. Jude Children's Research Hospital scientists recently ...
The immune system faces a delicate balancing act: it must be aggressive enough to fight infections and cancer, yet restrained ...
Even for a newly minted Nobel laureate, downtime is hard to find. Just a few weeks after winning the 2025 Nobel Prize in Physiology or Medicine for his discovery of regulatory T cells or Tregs, ...
In this interview, Dr. Kelemen discusses the advantages of lipid-based delivery systems and their potential to expand the ...
INDIANAPOLIS — New research by the IU School of Medicine is looking at new ways to fight aggressive cancers. Right now the focus is on enhancing treatment options for aggressive cancers like triple ...
An illustration of two blue-hued T cells next to one another against a dark background. Regulatory T cells, or T regs, make up the basis for a slew of biotech companies working to treat immunological ...
Work on peacemakers in the immune system won the 2025 Nobel Prize in physiology or medicine. The peacemakers are regulatory T cells, a type of immune cell that calms the immune system after it has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results